{
    "organizations": [],
    "uuid": "5e85b242f2b158e47c05836808f13c016a11e7d6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-palatin-technologies-announces-fda/brief-palatin-technologies-announces-fda-clearance-of-investigational-new-drug-application-for-pl-8177-idUSASB0BZJX",
    "ord_in_thread": 0,
    "title": "BRIEF-Palatin Technologies Announces FDA Clearance Of Investigational New Drug (Ind) Application For Pl-8177",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 3, 2018 / 12:32 PM / Updated 6 minutes ago BRIEF-Palatin Technologies Announces FDA Clearance Of Investigational New Drug (Ind) Application For Pl-8177 Reuters Staff 1 Min Read \nJan 3 (Reuters) - Palatin Technologies Inc: \n* PALATIN TECHNOLOGIES INC ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR PL-8177 FOR ULCERATIVE COLITIS \n* PALATIN TECHNOLOGIES INC - EXPECTS TO COMMENCE A PHASE 1 SINGLE AND MULTIPLE ASCENDING DOSE STUDY IN CURRENT QUARTER Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T14:32:00.000+02:00",
    "crawled": "2018-01-03T14:47:31.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "technology",
        "announces",
        "fda",
        "clearance",
        "investigational",
        "new",
        "drug",
        "ind",
        "application",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "palatin",
        "technology",
        "inc",
        "palatin",
        "technology",
        "inc",
        "announces",
        "fda",
        "clearance",
        "investigational",
        "new",
        "drug",
        "ind",
        "application",
        "ulcerative",
        "colitis",
        "palatin",
        "technology",
        "inc",
        "expects",
        "commence",
        "phase",
        "single",
        "multiple",
        "ascending",
        "dose",
        "study",
        "current",
        "quarter",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}